Tolga Sinan GÜVENÇ, Şeref KUL, Mustafa ÇALIŞKAN

Relationship between malnutrition and coronary microvascular dysfunction in patients with nonischemic dilated cardiomyopathy

Background/ aim: Malnutrition is common in patients with nonischemic dilated cardiomyopathy (DCM), especially in the end stages of the disease where heart failure symptoms predominate. Malnutrition has been associated with atherosclerosis in patients with chronic kidney disease, but it is unknown whether a similar relationship exists between malnutrition and coronary microvascular dysfunction (CMD). In the present study, we aimed to analyse whether indices of malnutrition were associated with coronary flow reserve (CFR) in patients with DCM. Materials and methods: A total of 33 cases who were prospectively followed up with by institutional DCM registry were found eligible for inclusion. Coronary flow reserve was measured with transthoracic echocardiography from the left anterior descending artery. The study sample was divided into 2 groups using a CFR cut-off value of 2.0. Geriatric nutritional index (GNI), prognostic nutritional index (PNI), and C-reactive protein/albumin ratio (CAR) were calculated. Results: A total of 17 out of 33 cases (51.5%) had a low (

PDF

___

1. Cannon RO , Cunnion RE, Parrillo JE, Palmeri ST, Tucker EE et al. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. Journal of the American College of Cardiology 1987;10 (6): 1190-1200.
2. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K et al. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. American Heart Journal 1994;127 (2): 376- 381.
3. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. European Heart Journal 2014; 35 (17):1101-1111
4. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105 (2): 186-193.
5. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349 (9058):1050-1053.
6. Zapatero A, Barba R, Gonzalez N, Losa JE, Plaza S et al. Influence of obesity and malnutrition on acute heart failure. Revista Espanola Cardiologia 2012; 65 (5):421-426.
7. Cheng YL, Sung SH, Cheng HM, Hsu PF, Guo CY et al. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. Journal of the American Heart Association 2017; 6 (6). pii: e004876. doi: 10.1161/ JAHA.116.004876
8. LaRocca TJ, Martens CR, Seals DR. Nutrition and other lifestyle influences on arterial aging. Ageing Research Reviews 2017 Oct; 39:106-119. doi: 10.1016/j.arr.2016.09.002
9. Caliskan M, Erdogan D, Gullu H, Muderrisoglu H. Higher serum gamma-glutamyltransferase levels are independently associated with impaired coronary microvascular function in patients with dilated cardiomyopathy. Atherosclerosis 2008; 201(1):163‐167. doi:10.1016/j.atherosclerosis.2008.01.010
10. Gullu H, Erdogan D, Caliskan M, Tok D, Kulaksizoglu S et al. Elevated serum uric acid levels impair coronary microvascular function in patients with idiopathic dilated cardiomyopathy. European Journal of Heart Failure 2007; 9 (5): 466‐468. doi:10.1016/j.ejheart.2006.10.019
11. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International 1999 ;55 (5): 1899- 911.
12. de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, et al, NECOSAD Study Group. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrology Dialysis Transplantation 2008; 23 (9): 2957- 2964. doi: 10.1093/ndt/gfn167
13. Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan et al. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007; 115 (5): 593-599.
14. Abd-E-Gawad WM, Abou-Hashem RM, Maraghy MO, Amin GE. The validity of Geriatric Nutrition Risk Index: simple tool for prediction of nutritional-related complication of hospitalized elderly patients. Comparison with Mini Nutritional Assessment. Clinical Nutrition Journal 2014;33 (6): 1108- 1116.
15. Keskin M, Hayıroğlu MI, Keskin T, Kaya A, Tatlısu MA et al. A novel and useful predictive indicator of prognosis in ST-segment elevation myocardial infarction, the prognostic nutritional index. Nutrition, Metabolism & Cardiovascular Diseases 2017; 27 (5): 438- 446. doi: 10.1016/j.numecd.2017.01.005
16. Karabağ Y, Çağdaş M, Rencuzogullari I, Karakoyun S, Artaç İ et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. Journal of Clinical Laboratory Analysis 2018; 32 (7): e22457. doi: 10.1002/jcla.22457
17. Aaron KJ, Sanders PW. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clinic Proceedings 2013; 88 (9): 987-995.
18. Blanch N, Clifton PM, Petersen KS, Willoughby SR, Keogh JB. Effect of high potassium diet on endothelial function. Nutrition, Metabolism & Cardiovascular Diseases 2014; 24 (9): 983-989.
19. Joris PJ, Plat J, Bakker SJ, Mensink RP. Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebocontrolled intervention trial. The American Journal of Clinical Nutrition 2016; 103 (5): 1260- 1266.
20. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016; 133 (2): 187-225.
21. Ros E, Hu FB. Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence. Circulation 2013; 128 (5): 553-565.
22. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. Journal of the American College of Cardiology 2009; 53 (4): 323-330. doi: 10.1016/j.jacc.2008.08.074
23. Sargento L, Vicente Simões A, Rodrigues J, Longo S, Lousada N et al. Geriatric nutritional risk index as a nutritional and survival risk assessment tool in stable outpatients with systolic heart failure. Nutrition, Metabolism & Cardiovascular Diseases 2017; 27 (5): 430-437. doi: 10.1016/j.numecd.2017.02.003
24. Cheng YL, Sung SH, Cheng HM, Hsu PF, Guo CY et al. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. Journal of the American Heart Association 201; 6 (6). pii: e004876. doi: 10.1161/ JAHA.116.004876
25. Caliskan M, Gullu H, Erdogan D, Ozulku M, Kulaksızoglu S et al. Association between serum total antioxidant status and coronary microvascular function in idiopathic dilated cardiomyopathy. Herz 2015; 40 (3): 487-494. doi: 10.1007/ s00059-013-4021-x
26. Tsiachris D, Tsioufis C, Dimitriadis K, Syrseloudis D, Rousos D et al. Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing. American Journal of Cardiology 2012; 109 (7): 1026-1030. doi: 10.1016/j.amjcard.2011.11.035
27. Premer C, Kanelidis AJ, Hare JM, Schulman IH. Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2019; 3(1): 1-13. doi: 10.1016/j. mayocpiqo.2018.12.006
28. Drexler H. Endothelium as a therapeutic target in heart failure. Circulation. 1998; 98 (24): 2652-2655.
29. Di Raimondo D, Tuttolomondo A, Buttà C, Miceli S, Licata G et al. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Current Pharmaceutical Design 2012;18 (28): 4385‐4413. doi:10.2174/138161212802481282
30. Miura R, Nakamura K, Miura D, Miura A, Hisamatsu K et al. Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells. Journal of Pharmacological Sciences 2006; 101 (3): 256‐259. doi:10.1254/ jphs.sc0060049
31. Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensinconverting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 2004; 109 (1): 53‐58. doi:10.1161/01.CIR.0000100722.34034.E4
32. Lethen H, Tries HP, Kersting S, Bramlage P, Lambertz H. Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension. The Journal of Clinical Hypertension 2011;13 (3): 155‐161. doi:10.1111/j.1751- 7176.2010.00401.x
33. Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation 2019; 139 (10): 1289‐1299. doi:10.1161/ CIRCULATIONAHA.118.038010